{"url_path":"/sec/cero/8-k/2026-06-26/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-26","source_url":"https://www.sec.gov/Archives/edgar/data/1870404/0001213900-26-072602-index.html","accession_number":"0001213900-26-072602","cik":"0001870404","ticker":"CERO","issuer_name":"CERO THERAPEUTICS HOLDINGS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1870404/0001213900-26-072602-index.html","primary_entity_key":"0001870404","primary_entity_name":"CERO THERAPEUTICS HOLDINGS, INC."},"word_count":82,"has_tables":true,"body_markdown":"**Item 9.01 Financial Statements and Exhibits.**\n\n \n\n**(d) Exhibits**\n\n** **\n\n**Exhibit No.**\n \n**Description**\n\n4.1\n \n[Amended and Restated Note (June 2026).](ea029602201ex4-1.htm)\n\n104\n \nCover Page Interactive Data File (embedded within the Inline XBRL document).\n\n \n\n1\n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities\nExchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\nDated: June 26, 2026\n**CERO THERAPEUTICS HOLDINGS, INC.**\n\n \n \n\n \nBy:\n/s/ Chris Ehrlich\n\n \nName:\nChris Ehrlich\n\n \nTitle:\nChief Executive Officer\n\n \n\n2"}